Cat. #161082
Aridanin
Cat. #: 161082
Sub-type: Inhibitor
Availability: 3-4 weeks
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: UJInvnt (Pty) Ltd
Primary Citation: https://pubchem.ncbi.nlm.nih.gov/compound/Aridanin
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Tool name: Aridanin
- Research fields: Cancer
- Molecular formula: C38H61NO8
- Tool sub type: Inhibitor
- Disease: THP-1 monocytes
- Primary target: Multiple targets
- Description: Anti cancer drug properties to combat multi-facorial resistance to established chemotherapeutics
- Purpose: Inhibitor
- Iupac: (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-1-0-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-car-boxylic acid
- Molecular weight: 456.71
Handling
- Storage conditions: Store at -20° C
- Shipping conditions: Dry Ice
Target Details
- Primary target: Multiple targets
- Ic50: 659.91
References
- https://pubchem.ncbi.nlm.nih.gov/compound/Aridanin
